AMRUBICIN for Thymoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where AMRUBICIN was used for Thymoma.
Most Reported Side Effects for AMRUBICIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease recurrence | 30 | 19.1% | 2 | 0 |
| Neutropenia | 22 | 14.0% | 4 | 3 |
| Drug ineffective | 21 | 13.4% | 12 | 2 |
| Interstitial lung disease | 17 | 10.8% | 2 | 3 |
| Febrile neutropenia | 16 | 10.2% | 5 | 2 |
| Leukopenia | 15 | 9.6% | 4 | 2 |
| Anaemia | 14 | 8.9% | 1 | 3 |
| Acute myeloid leukaemia | 13 | 8.3% | 5 | 4 |
| Disease progression | 12 | 7.6% | 5 | 1 |
| Thrombocytopenia | 12 | 7.6% | 2 | 2 |
| Small cell lung cancer | 10 | 6.4% | 2 | 0 |
| Decreased appetite | 8 | 5.1% | 1 | 1 |
| Off label use | 8 | 5.1% | 4 | 2 |
| Diarrhoea | 7 | 4.5% | 1 | 0 |
| Death | 6 | 3.8% | 6 | 0 |
Other Indications for AMRUBICIN
Small cell lung cancer (46)
Small cell lung cancer recurrent (26)
Small cell lung cancer extensive stage (17)
Product used for unknown indication (11)
Lung neoplasm malignant (8)
Neuroendocrine carcinoma (8)
Other Drugs Used for Thymoma
DOXORUBICIN (94)
CISPLATIN (93)
CYCLOPHOSPHAMIDE (92)
CARBOPLATIN (50)
PACLITAXEL (47)
ETOPOSIDE (34)
PEMBROLIZUMAB (30)
METHYLPREDNISOLONE (23)
RITUXIMAB (23)
NIVOLUMAB (21)